Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data

被引：0
|
作者：
Boesen, Kim [1 ]
Saiz, Luis Carlos [2 ,3 ]
Gotzsche, Peter C. [4 ]
Erviti, Juan [2 ,3 ,5 ]
机构：
[1] Copenhagen Univ Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Capital Reg,Rigshospitalet, Copenhagen, Denmark
[2] Navarre Hlth Serv, Unit Innovat & Org, Pamplona, Spain
[3] Navarre Inst Hlth Res IdiSNA, Pamplona, Navarre, Spain
[4] Inst Sci Freedom, Copenhagen, Denmark
[5] Univ Publ Navarra, , Navarre, Pamplona, Spain
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2025年 / 18卷 / 03期
关键词：
anticoagulants; atrial fibrillation; international normalized ratio; United States Food and Drug Administration; warfarin; NORMALIZED RATIO CONTROL; STROKE PREVENTION; EFFICACY; SAFETY;
D O I：
10.1161/CIRCOUTCOMES.124.011321
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation
    Lee, Joseph J.
    Ha, Andrew C. T.
    Dorian, Paul
    Verma, Maya
    Goodman, Shaun G.
    Friedrich, Jan O.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 140 : 62 - 68
  • [2] Reduced Dose Direct Oral Anticoagulants Compared to Warfarin With High Time in Therapeutic Range in Nonvalvular Atrial Fibrillation
    Jansson, Martin
    Sjogren, Vilhelm
    Sjalander, Sara
    Bjorck, Fredrik
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    CIRCULATION, 2019, 140
  • [3] Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study
    Lehto, Mika
    Luojus, Alex
    Halminen, Olli
    Haukka, Jari
    Putaala, Jukka
    Linna, Miika
    Mustonen, Pirjo
    Kinnunen, Janne
    Lehtonen, Ossi
    Teppo, Konsta
    Tiili, Paula
    Kouki, Elis
    Itainen-Stromberg, Saga
    Niemi, Mikko
    Aro, Aapo L.
    Hartikainen, Juha
    Airaksinen, K. E. Juhani
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [4] Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V
    Bjorck, F.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (03) : 415 - 425
  • [5] Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
    M. Jansson
    S. Själander
    V. Sjögren
    F. Björck
    H. Renlund
    B. Norrving
    A. Själander
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 415 - 425
  • [6] Safety and Efficacy Analysis of Warfarin versus Direct Oral Anticoagulants use in Atrial Fibrillation
    Goodier, Meagan
    Murthi, Julianne
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (05) : 1476 - 1477
  • [7] COMPARATIVE EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
    Done, N.
    Li, D.
    Woolley, A.
    Rose, A. J.
    Prentice, J. C.
    VALUE IN HEALTH, 2018, 21 : S6 - S7
  • [8] Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease
    Guo, Wenqin
    Tian, Xiaoyuan
    Qiu, Luwen
    Li, Lang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (18) : 2329 - 2330
  • [9] Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
    Mull, Hillary J.
    Shin, Marlena H.
    Engle, Ryann L.
    Linsky, Amy M.
    Kalver, Emily
    Lamkin, Rebecca
    Sullivan, Jennifer L.
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 1911 - 1922
  • [10] REPLY: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease
    Choi, Eue-Keun
    Lee, So-Ryoung
    Oh, Seil
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (18) : 2330 - 2331
12345